Rockies Venture Club
Orbit Genomics’ OrbiSeq platform is transforming how we diagnose, treat and prevent complex diseases including cancer, heart and neurological diseases. Orbit's proprietary OrbiSeq platform analyzes novel markers, microsatellites, that uniquely reflect both inherited risk and risk acquired from lifestyle and environmental exposures. Their first product addresses lung cancer however the technology can be used to identify a variety of therapeutic targets.
Company Long-Form Pitch & Q&A w/ Investors (40 Minutes) Product Demo (10 Minutes)
Outstanding Questions w/ Company (10 minutes) Optional - Investor Only Discussion (30 Minutes)
Date: Wednesday, February 7th Time: 1:30pm to 3:00pm MT Location: In-person at Thrive Workplace - Ballpark (1415 Park Ave. West, Denver, CO 80205) or via Zoom